Ovid Therapeutics Inc. (OVID): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Weighted Average Diluted Shares is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

70.58M
Year ended 2023-12-31
+6.5%
3-year compound annual growth
2020-12-31: 58.45M2021-12-31: 68.07M2022-12-31: 70.42M2023-12-31: 70.58M70.58M
2020-12-31 Weighted Average Diluted Shares (shares) 2023-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2023-12-3170.58M+0.2%2024-03-08, From 2023-01-01
2022-12-3170.42M+3.5%2024-03-08, From 2022-01-01
2021-12-3168.07M+16.5%2023-03-13, From 2021-01-01
2020-12-3158.45Mn/a2022-03-15, From 2020-01-01